Patents by Inventor Rita Ghosh

Rita Ghosh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED GLUCOCORTICOIDS
    Publication number: 20220411460
    Abstract: Certain embodiments are directed to modified glucocorticoid compounds having one or both of (i) a substitution of a halogen for the 11 hydroxy and/or (ii) reduction of the bond between carbon 4 and carbon 5 of the A ring.
    Type: Application
    Filed: June 29, 2021
    Publication date: December 29, 2022
    Inventors: Thomas J. Slaga, Daniel Glade, Anna Mancha Ramirez, Huiyun Liang, Rita Ghosh
  • ANGPTL4 AS A PROGNOSTIC MARKER FOR BLADDER CANCER
    Publication number: 20180203010
    Abstract: Certain embodiments are directed to methods and compositions for detecting or measuring ANGPTL4 in urinary bladder cancer sample from a subject and assessing the bladder cancer status of the subject.
    Type: Application
    Filed: January 17, 2018
    Publication date: July 19, 2018
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Rita Ghosh, Tiffani Houston, Neelam Mukherjee, Roble G. Bedolla, Eduardo Cardenas
  • Methods for assessing cancer recurrence
    Patent number: 9977033
    Abstract: Certain embodiments are directed to methods of identifying a subject having a higher risk of prostate cancer recurrence. The methods can include the step of measuring levels of one or more of FLIP, transcription factor Sp1, and transcription factor Sp3 in a prostate sample from the subject, wherein elevated levels of FLIP, transcription factor Sp1, and transcription factor Sp3 identify a subject as high risk for prostate cancer recurrence.
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: May 22, 2018
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Addanki Pratap Kumar, Izhar Singh Batth, Rita Ghosh, Roble Bedolla, Ian M. Thompson, Jr.
  • METHODS FOR ASSESSING CANCER RECURRENCE
    Publication number: 20140105933
    Abstract: Certain embodiments are directed to methods of identifying a subject having a higher risk of prostate cancer recurrence. The methods can include the step of measuring levels of one or more of FLIP, transcription factor Sp1, and transcription factor Sp3 in a prostate sample from the subject, wherein elevated levels of FLIP, transcription factor Sp1, and transcription factor Sp3 identify a subject as high risk for prostate cancer recurrence.
    Type: Application
    Filed: September 11, 2013
    Publication date: April 17, 2014
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Addanki Pratap Kumar, Izhar Singh Batth, Rita Ghosh, Roble Bedolla, Ian M. Thompson